Suppression of Conditioned Fear by Administration of CRF Receptor Antagonist CP-154,526

In order to examine the involvement of corticotropin-releasing hormone (CRF) receptor in the formation of anxiety, we investigated whether CRF receptor antagonist CP-154,526 suppressed conditioned fear stress. First, rats were individually subjected to 30 min of footshock. Twenty-four hours after footshock, the rats were again placed in the chamber and observed for 5 min without shock. CP-154,526 was administered 30 min before placing the rats in the chamber again. After that, CP-154,526 was once more administered 30 min before applying footshock. Administration of CP-154,526 30 min both before conditioned fear stress (placing the rats inside the cage but not applying footshock) and before actual footshock significantly reduced freezing behavior. These results show that CP-154,526 blocked both the acquisition and expression of conditioned fear, thus suggesting that the CRF receptor might be related to anxiety.

References

• 1 Baldwin H A, Rassnick S, Rivier J, Koob G F, Britton K T. CRF antagonist reverses the “anxiogenic” response to ethanol withdrawal in the rat.  Psychopharm.. 1991;  103 227-232
• 2 Bechara A, Tranel D, Damasio H, Adolphs R, Rockland C, Damasio A R. Double dissociation of conditioning and declarative knowledge relative to the amygdala and hippocampus in humans.  Science. 1995;  269 1115-1118
• 3 Britton K T, Lee G, Vale W, Rivier J, Koob G F. Corticotropin releasing factor (CRF) receptor antagonist blocks activation and ”anxiogenic“ actions of CRF in the rat.  Brain Res.. 1986;  369 303-306
• 4 Chappell P B, Smith M A, Kilts C D, Bissette G, Ritchie J, Anderson C, Nemeroff C B. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress.  J. Neurosci.. 1986;  6 2908-2914
• 5 Dunn A J, Berridge C W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?.  Brain Res. Rev.. 1990;  15 71-100
• 6 Fanselow M S. Conditional and unconditional components of post-shock freezing.  Pavlov. J. Biol. Sci.. 1980;  15 177-182
• 7 Finlay-Jones R, Brown G W. Types of stressful life event and the onset of anxiety and depressive disorders.  Psychol. Med.. 1981;  11 803-816
• 8 Holsboer F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety.  Journal of Psychiatric Research. 1999;  33 181-214
• 9 Inoue T, Tsuchiya K, Koyama T. Serotonergic activation reduces defensive freezing in the conditioned fear paradigm.  Pharmacol. Biochem. Behav.. 1996;  53 825-831
• 10 Kask A, Rago L, Harro J. Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats.  Neuroreport. 1997;  8 3645-3647
• 11 Koob G F, Heinrichs S C, Pich E M, Menzaghi F, Baldwin H, Miczek K, Brinton K T. The role of corticotropin-releasing factor in behavioural responses to stress. In D. J. Chadwick, Marsh, J., Ackrill, K. (Eds.) Corticotropin-Releasing Factor. (Ciba Foundation Symposium 172), John Wiley and Sons, Chichester 1993: 277-290
• 12 LaBar K S, LeDoux J E, Spencer D D, Phelps E A. Impaired fear conditioning following unilateral temporal lobectomy in humans.  J. Neurosci.. 1995;  15 6846-6855
• 13 Liang K C, Melia K R, Miserendino M J, Falls W A, Campeau S, Davis M. Corticotropin-releasing factor: long-lasting facilitation of the acoustic startle reflex.  J. Neurosci.. 1992;  12 2303-2312
• 14 Lundkvist J, Chai Z, Teheranian R, Hasanvan H, Bartfai T, Jenck F, Widmer U, Moreau J L. A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity.  Eur. J. Pharmacol.. 1996;  309 195-200
• 15 Matsumoto K, Ojima K, Watanabe H. Central corticotropin-releasing factor and benzodiazepine receptor systems are involved in the social isolation stress-induced decrease in ethanol sleep in mice.  Brain Res.. 1997;  753 318-321
• 16 Owens M J, Nemeroff C B. Physiology and pharmacology of corticotropin releasing factor.  Pharmacol. Rev.. 1991;  43 425-473
• 17 Owens M J, Vargas M A, Knight D L, Nemeroff C B. The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: acute time course, chronic treatment and abrupt withdrawal.  J. Pharmacol. Exp. Ther.. 1991;  258 349-356
• 18 Owens O J, Nemeroff C B. The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies.  Ciba Found. Symp.. 1993;  172 296-216
• 19 Owens M J, Vargas M A, Nemeroff C B. The effect of alprazolam on corticotropin-releasing factor neurons in the anxiety disorders.  J. Psychiat. Res.. 1993;  27 209-220
• 20 Roy-Byrne P P, Uhde T W, Post R M. Reduced TSH and prolactin responses to TRH in patients with panic disorder.  Am. J. Psychiat.. 1986;  143 803-507
• 21 Schulz C, Lehnert H. Activation of noradrenergic neurons in the locus coeruleus by corticotropin-releasing factor. A microdialysis study.   Neuroendocrino.. 1996;  63 454-458
• 22 Schulz D W, Mansbach R S, Sprouse J, Braselton J P, Collins J, Corman M, Dunaiskis A, Faraci S, Schmidt A W, Seeger T, Tingley F D, Winston E, Chen Y L, Heym J. CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.  Proc. Natl. Acad. Sci. USA.. 1996;  93 10477-10482
• 23 Sharkey J, Appel N M, De Souza E B. Alterations in local cerebral glucose utilization following central administration of corticotropin-releasing factor in rats.  Synapse. 1989;  4 80-87
• 24 Smith M A, Davidson J, Ritchie J C, Kudler H, Lipper S, Chappell P, Nemeroff C B. The corticotropin-releasing hormone test in patients with posttraumatic stress disorder.  Biol. Psychiatry.. 1989;  26 349-355
• 25 Smith G W, Aubry J M, Dellu F, Contarino A, Bilezikjian L M, Gold L H, Chen R, Marchuk Y, Hauser C, Bentley C A, Sawchenko P E, Koob G F, Vale W, Lee K F. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development.  Neuron.. 1998;  20 1093-1102
• 26 Sutton R E, Koob G F, Le Moal M, Rivier J, Vale W. Corticotropin-releasing factor produces behavioral activation in rats.  Nature. 1982;  297 331-333
• 27 Swiergiel A H, Takahashi L K, Kalin N H. Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat.  Brain Res.. 1993;  623 229-234
• 28 Timpl P, Spanagel R, Sillaber I, Kresse A, Reul J M, Stalla G K, Blanquet V, Steckler T, Holsboer F, Wurst W. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1110ee comments.  Nature Genetics.. 1998;  19 162-166
• 29 Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban P C, Bock R, Klein R, Schutz G. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety.  Nature Genetics. 1999;  231 99-103
• 30 Valentino R J, Page M E, Curtis A L. Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain Res. 1991: 555
• 31 Webster E L, Lewis D B, Torpy D J, Zachman E K, Rice K C, Chrousos G P. In vivo and in vitro characterization of Antalarmin, a nonpeptde corticotropin-releasing hormone (CRH) receptor antagonists: Suppression of pituitary ACTH release and peripheral inflammation.  Endocrinology. 1996;  137 5747-5750